We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-6.08%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$39.8B
AUM Growth
-$2.49B
(-5.9%)
Cap. Flow
+$696M
Cap. Flow
% of AUM
1.75%
Top 10 Holdings %
Top 10 Hldgs %
24.77%
Holding
1,335
New
62
Increased
793
Reduced
417
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$198M |
| 2 |
Synopsys
SNPS
|
+$159M |
| 3 |
Lam Research
LRCX
|
+$150M |
| 4 |
Intel
INTC
|
+$105M |
| 5 |
Western Union
WU
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$144M |
| 2 |
ServiceNow
NOW
|
+$108M |
| 3 |
Adobe
ADBE
|
+$108M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$104M |
| 5 |
B
Barrick Mining
B
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 36.37% |
| 2 | Technology | 23.79% |
| 3 | Energy | 8.84% |
| 4 | Healthcare | 6.99% |
| 5 | Financials | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Nuveen Quality Municipal Income Fund
NAD
$2.73B
| $16.3M | 0.04% |
1,042,868
+64,197
| +7% | +$1.04M |
|
277
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.66B
| $16.1M | 0.04% |
941,494
+56,798
| +6% | +$1.01M |
|
278
Qiagen
QGEN
$8.73B
| $16.1M | 0.04% |
294,391
-48,081
| -14% | -$2.68M |
|
279
Sanofi
SNY
$103B
| $16M | 0.04% |
331,587
+107,723
| +48% | +$5.48M |
|
280
Welltower
WELL
$168B
| $15.9M | 0.04% |
193,144
+51,876
| +37% | +$4.46M |
|
|
NVO
281
Novo Nordisk
NVO
$208B
| $15.8M | 0.04% |
330,072
+47,032
| +17% | +$2.27M |
|
282
AGCO
AGCO
$7.28B
| $15.8M | 0.04% |
128,562
-7,665
| -6% | -$1M |
|
283
Rithm Capital
RITM
$5.62B
| $15.7M | 0.04% |
1,429,523
-229,297
| -14% | -$2.36M |
|
284
Teva Pharmaceuticals
TEVA
$40.2B
| $15.7M | 0.04% |
1,607,322
+390,180
| +32% | +$3.65M |
|
285
Honeywell
HON
$78.2B
| $15.6M | 0.04% |
77,742
+6,573
| +9% | +$1.4M |
|
286
Novartis
NVS
$292B
| $15.5M | 0.04% |
189,781
+61,671
| +48% | +$5.55M |
|
|
CIM
287
Chimera Investment
CIM
$1.06B
| $15.4M | 0.04% |
346,175
-35,349
| -9% | -$1.59M |
|
288
Automatic Data Processing
ADP
$107B
| $15.4M | 0.04% |
76,932
+7,144
| +10% | +$1.47M |
|
289
Lowe's Companies
LOW
$119B
| $15.1M | 0.04% |
74,311
-4,092
| -5% | -$816K |
|
|
DTP
290
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
| $15M | 0.04% |
298,231
+65,673
| +28% | +$3.36M |
|
291
3M
MMM
$91.4B
| $14.8M | 0.04% |
100,994
+9,201
| +10% | +$1.49M |
|
292
Blackstone Mortgage Trust
BXMT
$2.46B
| $14.7M | 0.04% |
486,259
-47,579
| -9% | -$1.51M |
|
|
SEI
293
Solaris Energy Infrastructure
SEI
$3.4B
| $14.7M | 0.04% |
1,766,540
-16,170
| -0.9% | -$131K |
|
294
VEON
VEON
$3.68B
| $14.7M | 0.04% |
281,771
-89,527
| -24% | -$4.3M |
|
295
Arbor Realty Trust
ABR
$993M
| $14.4M | 0.04% |
774,931
-62,239
| -7% | -$1.12M |
|
296
Takeda Pharmaceutical
TAK
$53.7B
| $14.3M | 0.04% |
872,651
+249,686
| +40% | +$4.19M |
|
|
MMX
297
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $14.2M | 0.04% |
3,181,897
-86,024
| -3% | -$411K |
|
298
CVS Health
CVS
$134B
| $14.2M | 0.04% |
167,270
+2,191
| +1% | +$184K |
|
299
AvalonBay Communities
AVB
$27B
| $14.2M | 0.04% |
63,930
+16,747
| +35% | +$3.76M |
|
300
GSK
GSK
$103B
| $14.1M | 0.04% |
295,306
+80,207
| +37% | +$4.03M |
|
Similar funds
VanEck Associates's Q3 2021 Portfolio in Review
As of Q3 2021, VanEck Associates held 1,335 positions worth $39.8B, down 5.9% from $42.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
VanEck Associates's Q3 2021 filing shows 62 new, 793 increased, 417 reduced and 46 closed positions. Its largest new stake was Synopsys: 523,038 shares worth $157M. The largest sale was Newmont, an estimated $144M.
By sector, the portfolio is most concentrated in Materials at 36% of assets, down from 40% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q3 2021 buy was Synopsys: 523,038 shares worth $157M.
- VanEck Associates added most to TSMC in Q3 2021, an estimated $198M increase.
- VanEck Associates's biggest Q3 2021 reduction was Newmont, cutting an estimated $144M.
- VanEck Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $104M.
- VanEck Associates's ten largest holdings make up 25% of its $39.8B portfolio in Q3 2021.
- VanEck Associates opened 62 new positions and closed 46 in Q3 2021.
- VanEck Associates's portfolio value fell 5.9% quarter-over-quarter to $39.8B.
Based on VanEck Associates's 13F filing for Q3 2021, filed 3 Nov 2021.